Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.

Clonell launches the world’s first patient-specific embryonic stem cell therapy platform, aimed at incurable diseases with ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic ...

Stanford scientists discover how blocking 15-PGDH protein regenerates knee cartilage in mice and human tissue, offering hope ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...

Parvalbumin cells play a central role in keeping brain activity in equilibrium. They control nervcell signaling, reduce ...

TangGene names former GSK SVP Catherine Sohn as Senior Strategic Advisor, strengthening leadership as it advances a first-in-class in-vivo CD8⁺ Treg therapy. TangGene’s in-vivo CD8⁺ Treg approach has ...

A new Science study shows that blocking an ageing-linked protein can regenerate knee cartilage and prevent arthritis in mice, ...